Data coverage, completeness and provenance for ACTINOGEN MEDICAL LIMITED in the Stock Market API — Health Care · Biotechnology.
Source date: 2026-10-30T05:10:11. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-10-30 | 0.0420 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-29 | 0.0430 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-28 | 0.0400 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-27 | 0.0410 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-26 | 0.0430 | AUD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/ACW/prices · Price parameters and adjustment semantics
Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It develops Xanamem, an oral medication and inhibitor of the 11ß-HSD1 enzyme that achieves target engagement in the brain for the treatment of Alzheimer's disease, major depressive disorder, fragile x syndrome, and other neurological diseases. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia.
Website: https://actinogen.com.au · Profile fields populated: 60%
Share of stored fields populated in the anchor reporting period (FY2026), primary source yfinance. Full per-field breakdown: GET /api/v1/companies/ACW/financials.
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2026 (AUD) | 2026-06-30 | 27 | yfinance | ||||
| FY2025 (AUD) | 2025-06-30 | 27 | yfinance | ||||
| FY2024 (AUD) | 2024-06-30 | 27 | yfinance | ||||
| FY2023 (AUD) | 2023-06-30 | 26 | yfinance |
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/ACW
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/ACW/financials
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/ACW/metrics/summary
Report PDFs with LLM-ready markdown conversions where available.
GET /api/v1/companies/ACW/filings
Dated press releases and announcements with source links.
GET /api/v1/companies/ACW/news
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/ACW
Free tier — instant API key. Built for AI agents.